Co-Diagnostics adopts 25-for-1 reverse stock split
Co-Diagnostics filed an amendment to its Articles of Incorporation to effect a 25-for-1 reverse stock split, effective November 24, 2026. This corporate action increases the nominal price of its common stock but reduces the share count per holder.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed